Clinical trial
Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm…
NCT00120588 · University Hospital, Rouen, Other · Completed
Key facts
| NCT number | NCT00120588 |
|---|---|
| Title | Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth |
| Official title | Effect of Magnesium Sulfate on the Incidence of Periventricular Leukomalacia in the Very Preterm Neonate |
| Lead sponsor | University Hospital, Rouen, Other |
| Collaborators | Ministry of Health, France |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Preterm Birth, Periventricular Leukomalacia, Brain Ischemia, Intracranial Hemorrhages |
| Intervention type | Drug |
| Interventions | magnesium |
| Enrollment | 700 |
| Start date | Jul 1, 1997 |
| Completion | Jul 1, 2005 |
| First posted | Jul 18, 2005 |
| Last update posted | Jun 18, 2013 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: